Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Edward J. Victoria"'
Autor:
Andrej Sali, G. Michael Iverson, Marc A. Marti-Renom, Steven A. Krilis, Stephen W. Reddel, Ying-Xia Wang, David M. Marquis, Keith A. Cockerill, Matthew D. Linnik, Edward J. Victoria
Publikováno v:
The Journal of Immunology. 169:7097-7103
Autoantibodies against β2-glycoprotein I (β2GPI) appear to be a critical feature of the antiphospholipid syndrome (APS). As determined using domain deletion mutants, human autoantibodies bind to the first of five domains present in β2GPI. In this
Autor:
Christina A. Gamino, Huong-Thu Ton-Nu, Matthew D. Linnik, Edward J. Victoria, Stephen M. Coutts, M. E. Randow, G. M. Iverson, David S. Jones
Publikováno v:
Bioconjugate Chemistry. 10:480-488
Antibodies which bind beta2-glycoprotein I (beta2GPI) are associated with antiphospholipid syndrome. Synthetic peptide mimotopes have been discovered which compete with beta2GPI for binding to selected anti-beta2GPI. A thiol-containing linker was att
Autor:
Edward J. Victoria, Brian L. Baker, Daniel S. Sem, Stephen Coutts, Joshua Parks, Lin Yu, David S. Jones, David M. Marquis
Publikováno v:
Biochemistry. 37:16069-16081
The presence of high titers of anti-cardiolipin antibodies (ACA's) of autoimmune origin, which are known to bind to plasma beta2-glycoprotein I (aka apolipoprotein H), correlates clinically with autoimmune recurrent thrombosis. Soluble beta2-glycopro
Autor:
Martina E Randow, Christina A. Gamino, David S. Jones, Lin Yu, Edward J. Victoria, Stephen Coutts
Publikováno v:
Tetrahedron Letters. 39:6107-6110
Thioether cyclized peptide analogue, 1 , was synthesized using solid phase FMOC chemistry on HMPB-MBHA resin. α-Methylproline was introduced as an FMOC-alanyl-α-methylproline dipeptide, and the thioether was incorporated as FMOC-protected thioether
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 8:2129-2132
A series of mechanism-based inhibitors of phospholipase A2 (SIBLINKS) were synthesized. These new SIBLINKS are phospholipid analogues that contain a para-substituted phenyl 3,3-dimethylglutaryl group in the place of the sn-2 acyl chain. The effect of
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 343(1-2)
Understanding so-called anticardiolipin autoantibodies has been the focus of significant interest due to their accepted role in the pathology of antiphospholipid syndrome (APS). How these antibodies contribute to thrombosis, stroke and recurrent feta
Autor:
Merle S. Hayag, Edward J. Victoria, Eric M. Smith, Michael J. Branks, Matthew D. Linnik, Mary-Ann Campbell, David S. Jones, Keith A. Cockerill
Publikováno v:
International immunopharmacology. 3(12)
This study investigated the use of well-defined bioconjugate molecules to suppress antigen-specific B cell responses to domain I (DI) of human beta(2)-glycoprotein I (beta(2)GPI) in rats. DI is the dominant target of pathogenic autoimmune antibodies
Publikováno v:
Journal of autoimmunity. 18(4)
(Beta2-glycoprotein I (beta2GPI) is a plasma protein that plays an important role in the antigenic specificity of antiphospholipid autoantibodies (aPL). These antibodies are associated with an increased risk for thrombosis and recurrent foetal loss i
Autor:
Patricia A. McNeeley, Merle S. Hayag, Keith A. Cockerill, Christina A. Gamino, Jeffrey R. Hammaker, David S. Jones, G. Michael Iverson, Matthew D. Linnik, Edward J. Victoria, and Huong-Thu Ton-Nu, Martina E. Tedder
Publikováno v:
Bioconjugate chemistry. 12(6)
LJP 993, a tetravalent conjugate of the amino-terminal domain (domain 1) of beta2GPI, was synthesized, and studies were carried out to explore the ability of LJP 993 to bind anti-beta2GPI antibodies and to function as a B cell toleragen. Domain 1 was
Anticardiolipin (aCL) autoantibodies are associated with thrombosis, recurrent fetal loss, and thrombocytopenia. Only aCL found in autoimmune disease require the participation of the phospholipid binding plasma protein beta2 glycoprotein I (beta2GPI)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::585447a80dbd2b057392ff87394781bd
https://europepmc.org/articles/PMC28079/
https://europepmc.org/articles/PMC28079/